UnitedHealth Group Inc (NYSE:UNH) – Equities research analysts at Cantor Fitzgerald issued their FY2019 EPS estimates for shares of UnitedHealth Group in a research note issued on Wednesday. Cantor Fitzgerald analyst S. Halper expects that the healthcare conglomerate will earn $13.80 per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $280.00 target price on the stock.

Other research analysts also recently issued research reports about the company. Bank of America increased their price target on UnitedHealth Group from $230.00 to $240.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Citigroup increased their price target on UnitedHealth Group from $213.00 to $235.00 and gave the stock a “buy” rating in a research note on Wednesday, October 18th. Leerink Swann reiterated a “buy” rating and set a $240.00 price target (up previously from $225.00) on shares of UnitedHealth Group in a research note on Wednesday, October 18th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. Finally, Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $241.30.

UnitedHealth Group (NYSE UNH) traded up $4.73 during mid-day trading on Thursday, hitting $243.16. The stock had a trading volume of 6,233,080 shares, compared to its average volume of 2,990,000. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The company has a market cap of $235,100.00, a P/E ratio of 22.70, a price-to-earnings-growth ratio of 1.48 and a beta of 0.66. UnitedHealth Group has a 12 month low of $156.09 and a 12 month high of $243.90.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.79% and a net margin of 5.25%. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.11 EPS.

Several large investors have recently added to or reduced their stakes in UNH. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $121,000. Finally, Acrospire Investment Management LLC increased its position in shares of UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the last quarter. 86.09% of the stock is currently owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.20, for a total value of $1,111,000.00. Following the sale, the director now owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kenneth Irwin Shine sold 457 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,655 shares of company stock worth $7,469,083. Insiders own 0.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Analysts Issue Forecasts for UnitedHealth Group Inc’s FY2019 Earnings (UNH)” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2018/01/18/analysts-issue-forecasts-for-unitedhealth-group-incs-fy2019-earnings-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.